Literature DB >> 14637147

Effects of aging and ischemia on adenosine receptor transcription in mouse myocardium.

Kevin J Ashton1, Ulrika Nilsson, Laura Willems, Kirsty Holmgren, John P Headrick.   

Abstract

The well-documented age-related change in ischemic tolerance may result from impaired adenosine-mediated cardioprotection. Additionally, ischemia itself may potentially modify adenosine signalling, contributing to the post-ischemic phenotype. This study investigates age- and ischemia-dependent changes in adenosine receptor transcript levels (Adora) for the A(1), A(2A), A(2B), and A(3) receptor subtypes in mouse myocardium. Hearts from young (2-4 months) and moderately aged (16-18 months) mice were subjected to 20-min ischemia and 45-min reperfusion. Ischemic tolerance was impaired in aged hearts, which recovered less than 30% ventricular pressure development (compared with approximately 70% in young hearts), and lost 2-fold higher levels of lactate dehydrogenase during reperfusion (reflecting cellular disruption). Real-time PCR analyses revealed an age-related decline in Adora3 levels and induction of Adora2B. Curiously, this effect was mimicked by ischemia, which acutely reduced Adora3 levels and induced Adora2B in young (but not old) hearts. In contrast, in aged hearts ischemia selectively reduced levels of Adora1 transcript ( approximately 2-fold) without altering transcript levels for the other receptors. These results demonstrate selective modulation of cardioprotective adenosine receptor transcription by both aging and ischemia. Reduced A(3) adenosine receptor transcription may contribute to impaired ischemic tolerance in aged hearts, whereas changes in Adora transcription induced by ischemia may impact on the post-ischemic phenotype at later time points.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14637147     DOI: 10.1016/j.bbrc.2003.10.127

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Contributions of A2A and A2B adenosine receptors in coronary flow responses in relation to the KATP channel using A2B and A2A/2B double-knockout mice.

Authors:  Maryam Sharifi Sanjani; Bunyen Teng; Thomas Krahn; Stephen Tilley; Catherine Ledent; S Jamal Mustafa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-23       Impact factor: 4.733

Review 2.  Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology.

Authors:  S Jamal Mustafa; R Ray Morrison; Bunyen Teng; Amir Pelleg
Journal:  Handb Exp Pharmacol       Date:  2009

3.  Up-regulation of A 2B adenosine receptor in A 2A adenosine receptor knockout mouse coronary artery.

Authors:  Bunyen Teng; Catherine Ledent; S Jamal Mustafa
Journal:  J Mol Cell Cardiol       Date:  2008-03-12       Impact factor: 5.000

Review 4.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

5.  Adenosine inhibits renin release from juxtaglomerular cells via an A1 receptor-TRPC-mediated pathway.

Authors:  M Cecilia Ortiz-Capisano; Douglas K Atchison; Pamela Harding; Robert D Lasley; William H Beierwaltes
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-24

6.  Caffeine Protects Against Anticonvulsant-Induced Neurotoxicity in the Developing Rat Brain.

Authors:  Stefanie Endesfelder; Ulrike Weichelt; Cornelia Schiller; Marco Sifringer; Ivo Bendix; Christoph Bührer
Journal:  Neurotox Res       Date:  2017-06-22       Impact factor: 3.911

7.  Adenosine receptor expression in an experimental animal model of myocardial infarction with preserved left ventricular ejection fraction.

Authors:  Manuela Cabiati; Alessandro Martino; Letizia Mattii; Chiara Caselli; Tommaso Prescimone; Vincenzo Lionetti; Maria-Aurora Morales; Silvia Del Ry
Journal:  Heart Vessels       Date:  2013-07-11       Impact factor: 2.037

Review 8.  Purinergic signalling during development and ageing.

Authors:  Geoffrey Burnstock; Nicholas Dale
Journal:  Purinergic Signal       Date:  2015-05-20       Impact factor: 3.765

Review 9.  Adenosine A3 Receptor: A promising therapeutic target in cardiovascular disease.

Authors:  Shamama Nishat; Luqman A Khan; Zafar M Ansari; Seemi F Basir
Journal:  Curr Cardiol Rev       Date:  2016

Review 10.  Conditioning-induced cardioprotection: Aging as a confounding factor.

Authors:  Puneet Kaur Randhawa; Anjana Bali; Jasleen Kaur Virdi; Amteshwar Singh Jaggi
Journal:  Korean J Physiol Pharmacol       Date:  2018-08-27       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.